Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer

Yu,Hui; Liu,Fang; Sansas,Benoit; Kang,Bin; Preville,Xavier; Wu,Xianghua; Chang,Jianhua; Micol,Romain; Wang,Jialei; Meng,Xia

doi:10.3892/mco.2016.1106

Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer

Authors:
- Hui Yu
- Fang Liu
- Benoit Sansas
- Bin Kang
- Xavier Preville
- Xianghua Wu
- Jianhua Chang
- Romain Micol
- Jialei Wang
- Xia Meng
View Affiliations

Affiliations: Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China, Fudan University Shanghai Cancer Center‑Institut Mérieux Laboratory, Shanghai 200032, P.R. China, Transgene S.A., 67405 Illkirch Graffenstaden, France
Published online on: December 12, 2016 https://doi.org/10.3892/mco.2016.1106
Pages: 279-285

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-small-cell lung cancer (NSCLC) may establish an immunosuppressive tumor microenvironment that is conducive to tumor growth. Natural killer (NK) cells play a pivotal role in immunological surveillance. Activation of NK cells partially depends on the interactions between killer‑cell immunoglobulin‑like receptors (KIRs) and human leukocyte antigen (HLA) class I ligands. We herein investigated the association of KIRs and HLA ligands with survival in metastatic NSCLC (mNSCLC) patients treated with chemotherapy in a Chinese Han population. Polymerase chain reaction with sequence‑specific primers was used to type 15 KIRs at the DNA and mRNA level and 6 HLA ligands in 70 mNSCLC patients. Survival curves were estimated using the Kaplan‑Meier method and compared with the log‑rank test. Cox proportional hazard regression model was applied for multivariate survival analysis, with the stepwise selection, to determine independent predictors of survival. It was observed that patients with KIR2DS4del gene expression at the mRNA level or HLA‑Bw4T80 exhibited poor overall survival (OS). The multivariate analysis revealed that HLA‑Bw4T80 and KIR2DS4del expression were independent predictors of OS. This observation indicated that the KIR/HLA ligand is a promising predictor of survival in mNSCLC and may also provide a strategy for treatment stratification and patient management.

View Figures

View References

1	Carbone DP, Gandara DR, Antonia SJ, Zielinski C and Paz-Ares L: Non-small-cell lung cancer: Role of the immune system and potential for immunotherapy. J Thorac Oncol. 10:974–984. 2015. View Article : Google Scholar : PubMed/NCBI
2	Guillerey C and Smyth MJ: NK cells and cancer immunoediting. Curr Top Microbiol Immunol. 395:115–145. 2016.PubMed/NCBI
3	Höglund P and Brodin P: Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol. 10:724–734. 2010. View Article : Google Scholar : PubMed/NCBI
4	Parham P, Norman PJ, Abi-Rached L and Guethlein LA: Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci. 367:800–811. 2012. View Article : Google Scholar : PubMed/NCBI
5	Parham P: MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 5:201–214. 2005. View Article : Google Scholar : PubMed/NCBI
6	Campbell KS, Cella M, Carretero M, Lopez-Botet M and Colonna M: Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol. 28:599–609. 1998. View Article : Google Scholar : PubMed/NCBI
7	Katz G, Markel G, Mizrahi S, Arnon TI and Mandelboim O: Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol. 166:7260–7267. 2001. View Article : Google Scholar : PubMed/NCBI
8	Benson DM Jr and Caligiuri MA: Killer immunoglobulin-like receptors and tumor immunity. Cancer Immunol Res. 2:99–104. 2014. View Article : Google Scholar : PubMed/NCBI
9	Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK and Christmas SE: Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Hum Immunol. 71:976–981. 2010. View Article : Google Scholar : PubMed/NCBI
10	Boyton RJ and Altmann DM: Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 149:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
11	Martin MP, Borecki IB, Zhang Z, Nguyen L, Ma D, Gao X, Qi Y, Carrington M and Rader JS: HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics. 62:761–765. 2010. View Article : Google Scholar : PubMed/NCBI
12	Ferreiraa JA and Nyangomab SO: A multivariate version of the Benjamini-Hochberg method. Journal of Multivariate Analysis. 99:2108–2124. 2008. View Article : Google Scholar
13	Bao X, Hou L, Sun A, Qiu Q, Yuan X, Chen M, Chen Z and He J: Distribution of killer cell immunoglobulin-like receptor genes and 2DS4 alleles in the Chinese Han population. Hum Immunol. 71:289–292. 2010. View Article : Google Scholar : PubMed/NCBI
14	Yawata M, Yawata N, Draghi M, Little AM, Partheniou F and Parham P: Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med. 203:633–645. 2006. View Article : Google Scholar : PubMed/NCBI
15	Díaz-Peña R, Vidal-Castiñeira JR, Mulero J, Sánchez A, Queiro R and López-Larrea C: Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis. Clin Exp Immunol. 180:201–206. 2015. View Article : Google Scholar : PubMed/NCBI
16	La Manna G, Corsini S, Iannelli S, Cappuccilli ML, Comai G, Iorio M, Todeschini P, Carretta E, Scolari MP, Bontadini A and Stefoni S: Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome. Ann Transplant. 18:611–621. 2013. View Article : Google Scholar : PubMed/NCBI
17	Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, et al: The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression. AIDS. 29:507–517. 2015.PubMed/NCBI
18	Babor F, Manser AR, Fischer JC, Scherenschlich N, Enczmann J, Chazara O, Moffett A, Borkhardt A, Meisel R and Uhrberg M: KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse. Blood. 124:2248–2251. 2014. View Article : Google Scholar : PubMed/NCBI
19	De Re V, Caggiari L, De Zorzi M, Talamini R, Racanelli V, Da M, Buonadonna A, Zagonel V, Cecchin E, Innocenti F and Toffoli G: Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. PLoS One. 9:e849402014. View Article : Google Scholar : PubMed/NCBI
20	Wisniewski A, Jankowska R, Passowicz-Muszyńska E, Wiśniewska E, Majorczyk E, Nowak I, Frydecka I and Kuśnierczyk P: KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population. Hum Immunol. 73:927–931. 2012. View Article : Google Scholar : PubMed/NCBI
21	Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Aguilar AM Older, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, et al: KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med. 206:2557–2572. 2009. View Article : Google Scholar : PubMed/NCBI
22	Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S and Mandelboim O: MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol. 173:1819–1825. 2004. View Article : Google Scholar : PubMed/NCBI
23	Hong HA, Paximadis M, Gray GE, Kuhn L and Tiemessen CT: KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. Clin Immunol. 149:498–508. 2013. View Article : Google Scholar : PubMed/NCBI
24	Merino A, Malhotra R, Morton M, Mulenga J, Allen S, Hunter E, Tang J and Kaslow RA: Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples. J Infect Dis. 203:487–495. 2011. View Article : Google Scholar : PubMed/NCBI
25	Merino AM, Dugast AS, Wilson CM, Goepfert PA, Alter G, Kaslow RA and Tang J: KIR2DS4 promotes HIV-1 pathogenesis: New evidence from analyses of immunogenetic data and natural killer cell function. PLoS One. 9:e993532014. View Article : Google Scholar : PubMed/NCBI
26	Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin H, Xu J, Shi Q, Xie W and Zhang J: KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: A case-control study. PLoS One. 6:e256822011. View Article : Google Scholar : PubMed/NCBI
27	Giebel S, Nowak I, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Kyrcz-Krzemien S and Kusnierczyk P: Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia. 22:2129–2131. 2008. View Article : Google Scholar : PubMed/NCBI
28	Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I and Grzybowska E: Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer. Hum Immunol. 75:508–513. 2014. View Article : Google Scholar : PubMed/NCBI
29	Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P, Zanetti A, Trenti T, Ferrari C and Missale G: HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Clin Cancer Res. 19:5465–5473. 2013. View Article : Google Scholar : PubMed/NCBI
30	Purdy AK and Campbell KS: Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther. 8:2211–2220. 2009. View Article : Google Scholar : PubMed/NCBI
31	de Smith AJ, Walsh KM, Ladner MB, Zhang S, Xiao C, Cohen F, Moore TB, Chokkalingam AP, Metayer C, Buffler PA, et al: The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia. Blood. 123:2497–2503. 2014. View Article : Google Scholar : PubMed/NCBI